Pathways | S-all | R-all | S_R-all | |||
---|---|---|---|---|---|---|
 | U | D | U | D | U | D |
Ethylene | 21 | 7 | 14 | 3 | 4 | 8 |
Jasmonate | 4 | 2 | 2 | 0 | 0 | 0 |
Salicylic acid | 4 | 0 | 2 | 0 | 0 | 0 |
Receptor kinase | 20 | 5 | 9 | 3 | 5 | 4 |
Ca2+ signaling | 14 | 8 | 6 | 3 | 1 | 3 |
Biotic stress | 35 | 8 | 13 | 2 | 4 | 20 |
Wounding | 4 | 1 | 4 | 0 | 1 | 1 |
AP2/EREBP TF | 15 | 3 | 9 | 0 | 1 | 8 |
bHLH TF | 6 | 1 | 7 | 0 | 0 | 1 |
Zinc finger family TF | 12 | 1 | 5 | 1 | 4 | 4 |
WRKY domain TF | 10 | 1 | 7 | 0 | 2 | 1 |
Protein synthesis, targeting and folding | 6 | 148 | 3 | 30 | 71 | 9 |
Protein degradation-ubiquitin | 26 | 4 | 17 | 1 | 5 | 9 |
Protein posttranslational modification | 25 | 12 | 12 | 0 | 3 | 8 |
Bowman–Birk-type bran trypsin inhibitor | 7 | 1 | 6 | 1 | 0 | 5 |
Glucan endo-1,3-β-glucosidase | 11 | 2 | 6 | 0 | 1 | 9 |
Photosynthesis | 8 | 97 | 4 | 27 | 38 | 5 |
Tetrapyrrole synthesis | 0 | 23 | 0 | 10 | 14 | 1 |
Major CHO synthesis | 2 | 6 | 2 | 2 | 2 | 0 |
Major CHO degradation | 6 | 3 | 3 | 1 | 3 | 2 |
Lipid metabolism | 5 | 51 | 6 | 5 | 26 | 5 |
TCA, mitochondrial electron transport | 2 | 22 | 3 | 1 | 1 | 3 |